U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 100 points on Wednesday.
The Dow traded down 0.32% to 37,678.27 while the NASDAQ fell 1.16% to 15,681.95. The S&P 500 also fell, dropping, 0.74% to 5,013.98.
Invo Bioscience reported $1.38 million in quarterly sales, representing a 396.15% increase over sales of $278,140 from the same period last year. The company also said it remains on-track with its goal of reaching break-even or profitability within its current operations in 2024.
CXApp shares are trading higher Wednesday after the company announced record double digit Annual Recurring Revenue (ARR) growth in the fourth quarter of 2023 and 24% ARR growth for the full year 2023. CXAI attributed the ARR growth to two large Fortune 1000 logo contracts in the fourth quarter that are slated for deployment in the summer of 2024, leveraging the CXAI platform and in partnership with Google Cloud.
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.55% to 38,006.47 while the NASDAQ rose 0.24% to 15,903.38. The S&P 500 also rose, gaining, 0.40% to 5,071.74.
Prologis shares down after reporting Q1 results, with lower rental revenue and reduced FY24 guidance due to market conditions. CEO remains positive about long-term growth.
United Airlines reported first-quarter revenue of $12.539 billion, which beat the consensus estimate of $12.4 billion, according to Benzinga Pro. The company reported an adjusted quarterly loss 15 cents per share, which beat analyst estimates for a loss of 57 cents per share.
U.S. Bancorp reported a decline in revenue and net interest income for Q1 2024, but beat adjusted earnings expectations. FY24 guidance was also lowered.